Thrombosis Flashcards

1
Q

components of a thrombus

A
  • fibrin

- platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

definition of a thrombus

A

a solid mass, formed in the circulation from the constituents of the blood during life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

where do atheromas tend to develop?

A

areas of turbulent blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are white thrombi formed?

A

Platelets adhere to the damaged vascular

endothelium and aggregate in response to ADP and TXA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what limits the growth of thrombi?

A
  • PGI2

- NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does plaque rupture lead to thrombus formation?

A

Plaque rupture leads to the exposure of blood containing factor VIIa to tissue factor within
the plaque, which may trigger blood coagulation and lead to thrombus formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

main component of a white thrombus

A

platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are red thrombi?

A

these are also known as venous thrombi and contains more fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

management of venous thrombi

A

antifibrin like heparin or warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

management of arterial thrombi

A

antiplatelet like aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

major causes of venous thrombi

A
  • stasis

- hypercoagulability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is postphlebetic syndrome?

A

Chronic venous
obstruction following thrombosis in the deep veins of the leg frequently results in a
permanently swollen limb and may lead to ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

patient factors that are risk factors for VTE

A
  • age
  • high BMI
  • varicose veins
  • frequent/recent continuous travel
  • immobility
  • pregnancy and puerperium
  • thrombophilia
  • oestrogen therapy
  • dysfibrinogenaemia
  • plasminogen deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

diseased stated that are risk factors for VTE

A
  • trauma/surgery
  • cardiac/resp failure
  • malignancy
  • recent MI/CVA
  • acute medical illness/severe infection
  • inflammatory bowel disease
  • behcet’s disease
  • nephrotic syndrome
  • myeloproliferative disorders
  • paroxysmal noctural haemoglobinuria
  • paraproteinaemia
  • sickle cell anaemia
  • central venous catheter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

who has problems with blood stagnation?

A
  • long distance flights
  • bedridden patients
  • sedentary occupations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

problems with coagulability

A
  • clotting factors and natural anticoagulants
  • pregnancy
  • oestrogen therapy/hormone
  • post-inflammation/surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what causes endothelial damage?

A
  • trauma
  • fractures
  • cannulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what’s Virchow’s triad?

A
  • circulatory stasis
  • vascular wall injury
  • hypercoaguable state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

risk factors for arterial thrombosis

A
  • HTN
  • DM
  • hypercholesterolaemia
  • smoking
  • hyperlipidaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the 3 systems involved in clot formation?

A
  • platelets
  • clotting factors
  • endothelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are steps does the platelet go through in clotting?

A
  • platelet activation
  • platelet adhesion
  • platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what substances mediate platelet adhesion?

A
  • vWF

- GPIb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what substances change the shape of the platelet?

A
  • ADP
  • Ca
  • serotonin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

which substances mediate platelet aggregation?

A
  • GPIIb/IIIa
  • fibrinogen
  • prostacyclin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

how many pathways does the clotting cascade have?

A

2; intrinsic and extrinsic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is the result of the clotting cascade?

A

conversion of fibrinogen into fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is PT?

A

prothrombin time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

another name for PT

A

INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

which pathways does the INR monitor?

A
  • extrinsic

- common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

which clotting factors are monitored through the INR?

A
  • 5
  • 7
  • 10
  • prothrombin
  • fibrinogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

normal INR

A

1.0

32
Q

INR for people on warfarin

A

2.0-3.0

33
Q

what does a high INR indicate?

A

bleeding risk

34
Q

what dose a low INR indicate?

A

thrombosis risk

35
Q

which medication can be monitored using APTT?

A

heparin

36
Q

what is APTT?

A

activated prothrombin clotting time

37
Q

which pathways are monitored through APTT?

A
  • intrinsic

- common

38
Q

which factors are monitored through the APTT?

A
  • 5
  • 8
  • 9
  • 10
  • 11
  • 12
  • prothrombin
  • fibrinogen
39
Q

causes of a prolonged APTT

A
  • heparin use
  • antiphospholipid antibody
  • coagulation factor deficiency
  • sepsis
  • presence of antibodies against coagulation factors
40
Q

what is the principle enzyme for haemostasis?

A

thrombin

41
Q

what does thrombin do?

A
  • fibrinogen to fibrin
  • activates V, VIII, XI and XIII
  • activates Protein C, when bound to thrombomodulin
  • activates platelets
  • plasminogen to plasmin (this breaks the clot)
42
Q

what do we use to break down clots?

A

thrombolytics

43
Q

what do protein C and S collectively inhibit?

A

factor V

44
Q

what are people deficient in protein C or S prone to?

A

thrombosis

45
Q

prevention and treatment of arterial thrombosis

A
  • minimise risk factors for thrombosis
  • antiplatelet drugs
  • thrombolytic therapy
46
Q

what are the main antiplatelet drugs?

A
  • aspirin

- clopidogrel

47
Q

what does aspirin bind to?

A

cyclooxygenase, which reduces the platelet production of TXA2

48
Q

what does clopidogrel inhibit?

A

ADP receptor on platelet cell membranes

49
Q

types of thrombolytics

A
  • streptokinase

- plasminogen activators

50
Q

what does streptokinase do?

A
  • binds to plasminogen, activating it to produce more plasmin
  • risk of haemorrhage as indiscriminate of the clots it breaks down
51
Q

example of a plasminogen activator

A

alteplase i.e. TPA

52
Q

which of the thrombolytic drugs are antigenic and thus, can cause allergic reasons?

A

streptokinase

53
Q

what are the 2 types of oral anticoagulants?

A
  • coumarins

- indanediones

54
Q

the most common coumarin used

A

warfarin

55
Q

what does warfarin inhibit?

A

the reductase enzyme which activates Vitamin K, making it impossible to produce factors 2, 7, 9, 10

56
Q

what will be prolonged as warfarin is used?

A
  • PTT (factor 7, 10)

- APTT (factor 9, 10)

57
Q

in which situation should the INR be between 3 and 4?

A
  • recurrent VTE
  • antiphospholipid syndrome
  • mechanical prosthetic heart valve
  • coronary artery graft thrombosis
  • stroke prevention
58
Q

in which situations should the INR be between 2 and 3?

A
  • PE
  • proximal and calf DVT
  • recurrent VTE wo warfarin therapy
  • symptomatic inherited thrombophilia
  • atrial fibrillation
  • cardioversion
  • mural thrombus
  • cardiomyopathy
59
Q

how long should you give warfarin in situations of VTE?

A
  • at least 6w-3m if the cause goes away
  • at least 6m if no cause is found
  • indefinite if no cause is found or if this is persistent
60
Q

contraindications to anticoagulants

A
  • severe uncontrolled hypertension
  • non-thromboembolic strokes
  • peptic ulceration
  • severe liver and renal disease
  • pre-existing haemostatic defects
  • non-compliance
  • pregnancy
61
Q

what happens if the INR is too high?

A
  • depending on the INR level, reduce or stop the warfarin, until the INR is lower than 5
  • if above 8 and the patient is not bleeding, administer Vitamin K
  • if there is a major bleed, stop the warfarin and give a prothrombin complex concentrate
62
Q

what enhances warfarin action?

A
  • alcohol
  • aspirin
  • NSAIDs
63
Q

what decreases warfarin action?

A
  • contraceptive steroids

- vitamin K

64
Q

example of an anti-Xa inhibitor

A
  • rivaroxaban (xarelto) (you do not need monitoring with this)
65
Q

example of an active direct thrombin

A

dabigatran

66
Q

what does heparin bind to?

A

anti-thrombin

67
Q

actions of heparin

A
  • activates anti-thrombin
  • inhibits factor 10
  • mild inhibitor of all factor except 7
68
Q

which clotting screen tests are altered due to heparin?

A
  • PT (prolonged)

- APTT (more prolonged)

69
Q

what is the target ratio for heparin patients?

A

1.5-2.0

70
Q

which drug can be used as an antidote in high dose heparin situations?

A

protamine sulfate

71
Q

why are LMWH heparins used instead of UFH?

A
  • higher bioavailability
  • more potent against factor Xa than IIa (lower risk of bleeding)
  • longer half-life than normal heparin
  • have little effect on the clotting screen
  • less likely to cause HIT
72
Q

what eliminates the LMWH?

A

kidneys

73
Q

administration method of LMWH

A

subcutaneous

74
Q

administration method of UFH

A

IV

75
Q

what complication can happen with heparin?

A
  • bleeding
  • heparin-induced thrombocytopenia
  • osteoporosis
  • hyperkalaemia
76
Q

when does heparin-induced thrombocytopenia happen?

A

5-14 days

77
Q

contraindications of heparin

A
  • bleeding disorders
  • low platelet count
  • HIT
  • peptic ulcer
  • cerebral haemorrhage
  • severe hypertension
  • neurosurgery